Pallas Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Pallas Capital Advisors LLC
- $2.24 Billion
- Q1 2025
A detailed history of Pallas Capital Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 2,480 shares of VRTX stock, worth $1.26 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,480
Previous 2,461
0.77%
Holding current value
$1.26 Million
Previous $991,000
21.29%
% of portfolio
0.05%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,794Shares Held
224MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.1 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.31 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...